61: Multi-Institutional Phase II Study of Pentostatin for the Treatment of Refractory Chronic GVHD (cGVHD) in Children: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study
David A. Jacobsohn(Children's National), Georgia B. Vogelsang(Johns Hopkins University), Andrew L. Gilman(Gene Therapy Laboratory), Brittan Browning(University of Utah), Eneida R. Nemecek(Oregon Health & Science University), K. Thormann(Northwestern University), Leslie Lehmann(Harvard University)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION
|Transplantation|1987|914
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
|Biology of Blood and Marrow Transplantation|2009|595
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577